EPS1.3 Safety, tolerability and early signs of efficacy with riociguat for the treatment of adult Phe508del homozygous cystic fibrosis patients: study design and rationale for the Rio-CF study
| Autor: | Derichs, N., Taylor-Cousar, J., Tullis, E., Davies, J., Nazareth, D., Downey, D.G., Rosenbluth, D., Fajac, I., Malfroot, A., Bakker, M., Clancy, J.P., Uluer, A., Castellani, C., Sermet-Gaudelus, I., Ahrens, R.C., Sutharsan, S., Welte, T., Gust, T., Kaiser, A., Hoffmann, A., Ratjen, F., Rowe, S. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S36-S36 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect